Related Experiment Video
Updated: Aug 30, 2025
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
12.3K
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement
Emma Kroeze1, Laura Arias Padilla2, Max Bakker1
1Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Cancers
|August 26, 2022
Summary
B-cell lymphoblastic lymphoma (BCP-LBL) and B-cell acute lymphoblastic leukemia (BCP-ALL) are distinct pediatric B-cell malignancies. Hepatosplenomegaly and peripheral blood involvement effectively differentiate BCP-ALL from BCP-LBL, impacting survival outcomes.
Area of Science:
- Pediatric Hematology Oncology
- Cancer Biology
- Clinical Hematology
Background:
- B-cell lymphoblastic lymphoma (BCP-LBL) and B-cell acute lymphoblastic leukemia (BCP-ALL) arise from immature B-cells.
- BCP-ALL is a common childhood cancer, extensively studied with evolving treatments.
- BCP-LBL is rare in children (1% of hematological malignancies) with largely static treatment protocols.
Purpose of the Study:
- To analyze and compare the clinical characteristics and outcomes of pediatric BCP-LBL and BCP-ALL.
- To identify key clinical discriminators between BCP-LBL and BCP-ALL.
- To evaluate survival differences based on diagnosis and age in pediatric precursor B-cell malignancies.
Main Methods:
- Retrospective analysis of clinical data from 364 pediatric patients.
- Patients categorized into BCP-LBL (n=210) and BCP-ALL (n=154) groups.
- Statistical comparison of clinical features and overall survival rates.
Main Results:
- Hepatosplenomegaly (80% BCP-ALL vs 2% BCP-LBL) and peripheral blood involvement (95% BCP-ALL vs 2% BCP-LBL) are key discriminators.
- Overall survival differs significantly between BCP-LBL and BCP-ALL in children aged 1-18 years (p=0.0080).
- Infants (0-1 years) with BCP-LBL show significantly worse outcomes compared to older pediatric BCP-LBL patients (p<0.0001).
Conclusions:
- Pediatric B-cell malignancies represent a spectrum from medullary to extramedullary disease.
- Clinical presentation, particularly hepatosplenomegaly and blood involvement, aids in differentiating BCP-ALL from BCP-LBL.
- Age is a critical factor in BCP-LBL prognosis, with infants facing poorer outcomes.
Related Concept Videos
01:16Primary Lymphoid Organs
4.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
4.5K
01:23Cells of the Adaptive Immune Response
3.6K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
3.6K
01:22Bone Marrow Sampling and Transplants
482
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
482
01:15Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
01:21Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K